Lmax and imiquimod 3.75%: the new standard in AK management.

Stockfleth, E

Lmax and imiquimod 3.75%: the new standard in AK management. [electronic resource] - Journal of the European Academy of Dermatology and Venereology : JEADV Jan 2015 - 9-14 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1468-3083

10.1111/jdv.12824 doi


Adjuvants, Immunologic--therapeutic use
Aminoquinolines--therapeutic use
Humans
Imiquimod
Keratosis, Actinic--drug therapy